Citations for
1XIAP, XLP2
Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency.
Dziadzio M, Ammann S, Canning C, Boyle F, Hassan A, Cale C, Elawad M, Fiil BK, Gyrd-Hansen M, Salzer U, Speckmann C, Grimbacher B.
J Clin Immunol 35(5):439-44. doi: 10.1007/s10875-015-0166-0. Epub 2015 May 6. 2015
2LYP, SH2D1A, XIAP, XLP2
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
Pachlopnik Schmid J, Canioni D, Moshous D, Touzot F, Mahlaoui N, Hauck F, Kanegane H, Lopez-Granados E, Mejstrikova E, Pellier I, Galicier L, Galambrun C, Barlogis V, Bordigoni P, Fourmaintraux A, Hamidou M, Dabadie A, Le Deist F, Haerynck F, Ouachée-Chardin M, Rohrlich P, Stephan JL, Lenoir C, Rigaud S, Lambert N, Milili M, Schiff C, Chapel H, Picard C, de Saint Basile G, Blanche S, Fischer A, Latour S.
Blood 117(5):1522-9. Epub 2010 Nov 30. 2011
3LYP, XIAP, XLP2
XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.
Rigaud S, Fondaneche MC, Lambert N, Pasquier B, Mateo V, Soulas P, Galicier L, Le Deist F, Rieux-Laucat F, Revy P, Fischer A, de Saint Basile G, Latour S.
Nature 444(7115):110-4. 2006